Skip to content

Hollis C Karoly

11 papers in the library · 20 citations · publishing 2021-2026

Papers

Sort Most recent Most cited

Neurophysiological and Behavioural Effects of Combined Cannabis Concentrates and Alcohol Among People Who Regularly Use Alcohol and Cannabis.

Addiction Biology November 2026 Eleftherios M Hetelekides, Patricia L Davies, Mark A Prince et al.

Increasingly potent concentrated cannabis products containing high levels of Δ9-tetrahydrocannabinol (THC) are being consumed with alcohol. This combination is known to acutely impair cognitive and psychomotor abilities, although few studies have evaluated alcohol and cannabis co-use using neural measures. This naturalistic feasibility study explored the acute effects of co-intoxication on...

Kava (Piper methysticum) consumption patterns and conceptualizations: results from an online survey.

Substance Abuse Treatment, Prevention, and Policy May 5, 2026 Katherine G. W. Hill, Cianna J Piercey, Hollis C Karoly et al.

'Kava,' or 'kava kava,' (Piper methysticum) is a psychoactive plant indigenous to the Pacific Islands. Historical consumption is reported to provide anxiolytic and sedating effects. In regions where kava is native, it has been used in religious and cultural practices, as well as for medicinal purposes. The mechanisms by which kavalactones - the best studied psychoactive constituent of kava -...

DOI: 10.1186/s13011-026-00728-3 (opens in new tab) Full text (opens in new tab) Piper methysticum Alcohol Harm-reduction Kava +1

Characteristics of adverse reactions to kratom and implementation of harm reduction strategies in a sample of ethnobotanical tea bar patrons in Colorado.

Harm Reduction Journal March 2, 2026 Cianna J Piercey, Joseph Cameron, Riley Ahern et al.

Kratom is a psychoactive botanical that is increasingly popular in the United States. While potential risks of kratom use have been identified, research on harm reduction strategies and contextual factors contributing to adverse reactions is limited. Given that kratom is federally unregulated at present, and a variety of kratom products are widely available on the commercial market, more data...

DOI: 10.1186/s12954-025-01382-x (opens in new tab) Full text (opens in new tab) Adverse effects Ethnobotanical tea bars Field survey Harm reduction +3

Psilocybin Outside the Clinic

JAMA Psychiatry November 5, 2025 Kent E. Hutchison, Judith Hooper, Hollis C Karoly 10 citations

Importance Psilocybin use has surged in the US following decriminalization efforts and promising clinical trial results. Mirroring early cannabis legalization, public access and enthusiasm are outpacing regulatory oversight and scientific understanding, posing potential risks to public health. Objective To review emerging evidence on the public health implications of unregulated psilocybin...

DOI: 10.1001/jamapsychiatry.2025.3038 (opens in new tab) Psilocybin Hallucinogen Clinical trial Public health +4

"Other" Substance Use Among American Indian Reservation-Area High School Youth.

Journal of Studies on Alcohol and Drugs May 20, 2025 Mark A. Prince, Brandon Paez, Jessica L Morse et al.

High school youth have an elevated risk of substance use. Some substances (e.g., inhalants, MDMA) used by youth are overlooked or grouped in an "other" category. Compared to other racial/ethnic groups, American Indian (AI) youth may be at higher risk of using these substances. The purpose of this study is to examine the prevalence and patterns of use of "other" substances among youth living on...

DOI: 10.15288/jsad.25-00090 (opens in new tab) Full text (opens in new tab) Substance abuse Indigenous health Youth behavior Drug trends +1

Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence.

Psychedelic Medicine December 1, 2024 Cianna J Piercey, Bethany A. Gray, Angelina Sung et al. 5 citations

Approximately 8.5 million Americans over the age of 12 endorsed past year psychedelic use in 2022, with 1.4 million individuals initiating use during this time. Although emerging evidence indicates there may be beneficial aspects of psychedelic use, there is a need to understand how individuals might mitigate potential risks within nonclinical contexts, such as through the use of protective...

DOI: 10.1089/psymed.2023.0052 (opens in new tab) Full text (opens in new tab) Protective behavioral strategies Harm reduction Safety protocols Safe use +4

Simultaneous cannabis and psychedelic use among festival and concert attendees in Colorado: characterizing enhancement and adverse reactions using mixed methods.

Journal of Cannabis Research July 11, 2024 Cianna J Piercey, Eleftherios Hetelekides, Hollis C Karoly 5 citations

Background: Most studies examining the simultaneous use of cannabis with other drugs have focused on cannabis and alcohol, with fewer studies examining simultaneous use of cannabis with other drugs. The United States is currently experiencing an upward trend in psychedelic use and there is an increasing need to characterize cannabis and psychedelic drug interactions to best inform public health...

Baseline affective symptomatology moderates acute subjective effects of high potency THC and CBD cannabis concentrates.

Experimental and Clinical Psychopharmacology December 2023 Renée Martin-Willett, Carillon J. Skrzynski, Hollis C Karoly et al.

Highly potent cannabis concentrates are widely available and associated with affective disturbance and cannabis use disorder. Little is known about the effects of concentrated Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) and their relationship to long-term affect. We explored how baseline affective symptoms (anxiety and depression) relate to acute (i.e., immediate or short-term)...

Protocol for a mobile laboratory study of co-administration of cannabis concentrates with a standard alcohol dose in humans.

PLoS One 2022 Hollis C Karoly, Mark A. Prince, Noah N Emery et al.

Cannabis is commonly used among people who drink alcohol, yet evidence on acute effects of co-use is conflicting. Two important variables that may influence the effects of cannabis and alcohol are cannabinoid content (i.e., the ratio of cannabidiol [CBD] and 9-tetrahydrocannabinol [THC]) as well as the order of use (i.e., cannabis before alcohol vs. alcohol before cannabis). Research is mixed...

Effects of cannabidiol in cannabis flower: Implications for harm reduction.

Addiction Biology 2022 Laurel P Gibson, Hollis C Karoly, Jarrod M. Ellingson et al.

Using a federally compatible, naturalistic at-home administration procedure, the present study examined the acute effects of three cannabis flower chemovars with different tetrahydrocannabinol (THC) to cannabidiol (CBD) ratios, in order to test whether chemovars with a higher CBD content produce different effects. Participants were randomly assigned to ad libitum administration of one of three...

A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment

Psychopharmacology October 27, 2021 L. C. Bidwell, Hollis C Karoly, M. O. Torres et al.

Published studies examining the effects of cannabis have largely utilized forms of cannabis that are not representative of the legal market products currently available. The present study aimed to characterize naturalistic use of legal market flower and edible products by examining associations among blood cannabinoids and amount of THC consumed as well as physiological, cognitive, and...